NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ActiTrexx GmbH

ActiTrexx GmbH

Private
MainzHealthcare & Life Scienceshttps://www.actitrexx.de/

Last Round

Series A

Mar 2, 2021

Total Funding Raised

$8.65M

Company Overview

ActiTrexx GmbH is a biotechnology company developing cellular and biologic therapies based on activated regulatory T cells to address T cell-mediated autoimmune and autoinflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyregulatory T cellsTregsGraft-versus-Host DiseaseGvHDallogeneic therapyadvanced therapy medicinal productsATMPautoimmune disease treatmentoff-the-shelf cell therapybiotech R&Dclinical-stage biotechcell manufacturingimmunotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ActiTrexx GmbH Comparables

Compare ActiTrexx GmbH with similar companies based on industry and business-model similarity.

ActiTrexx GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tr1X
85%
Cellenkos, Inc.
83%
Quell Therapeutics
79%

ActiTrexx GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 2, 2021

ActiTrexx GmbH Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 35% MoM, from 66 to 89.

ActiTrexx GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ActiTrexx GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ActiTrexx GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersMainz
Employee Range9
Year Founded2020
Last FundingMar 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.